Related references
Note: Only part of the references are listed.A systematic review of the association of neuregulin 4, a brown fat-enriched secreted factor, with obesity and related metabolic disturbances
Helda Tutunchi et al.
OBESITY REVIEWS (2020)
A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity
Helda Tutunchi et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2020)
Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19
Samad Ghaffari et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes
Helda Tutunchi et al.
PHARMACOLOGICAL RESEARCH (2020)
The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults
Helda Tutunchi et al.
BMC RESEARCH NOTES (2020)
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
Carolina M. Perdomo et al.
NUTRIENTS (2019)
The effects of oleoylethanolamide, an endogenous PPAR-α agonist, on risk factors for NAFLD: A systematic review
Helda Tutunchi et al.
OBESITY REVIEWS (2019)
Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
Laura Orio et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Substantial fat mass loss reduces low-grade inflammation and induces positive alteration in cardiometabolic factors in normal-weight individuals
H. V. Sarin et al.
SCIENTIFIC REPORTS (2019)
Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour
J. Sihag et al.
OBESITY REVIEWS (2018)
Oleoylethanolamide increases the expression of PPAR-A and reduces appetite and body weight in obese people: A clinical trial
Payahoo Laleh et al.
APPETITE (2018)
Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial
Laleh Payahoo et al.
ADVANCED PHARMACEUTICAL BULLETIN (2018)
Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration
Maria Anton et al.
ADDICTION BIOLOGY (2017)
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Barbara Gross et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Oleic acid-derived oleoylethanolamide: A nutritional science perspective
Kate J. Bowen et al.
PROGRESS IN LIPID RESEARCH (2017)
Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPARα signaling and inhibiting the NF-κB and ERK1/2/AP-1/STAT3 pathways
Lichao Yang et al.
SCIENTIFIC REPORTS (2016)
Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients
Gabriela Paredes-Turrubiarte et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2016)
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
Michal Pawlak et al.
JOURNAL OF HEPATOLOGY (2015)
Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats
Long Li et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
Ling Chen et al.
ONCOTARGET (2015)
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats
Aline Sayd et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling Pathway
Ning Zhang et al.
ONCOTARGET (2014)
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
Howard C. Masuoka et al.
YEAR IN DIABETES AND OBESITY (2013)
Inflammation as a Link between Obesity and Metabolic Syndrome
Faloia Emanuela et al.
JOURNAL OF NUTRITION AND METABOLISM (2012)
NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma
Tom Luedde et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
Elisa Fabbrini et al.
HEPATOLOGY (2010)
Short-Term Therapy with Peroxisome Proliferation-Activator Receptor-α Agonist Wy-14,643 Protects Murine Fatty Liver Against Ischemia-Reperfusion Injury
Narci C. Teoh et al.
HEPATOLOGY (2010)
The Role of Inflammation in Cholestasis: Clinical and Basic Aspects
Astrid Kosters et al.
SEMINARS IN LIVER DISEASE (2010)
Toll-like receptors as targets in chronic liver diseases
A. Mencin et al.
GUT (2009)
Non-alcoholic fatty liver disease: The mist gradually clears
Nimantha Mark Wilfred de Alwis et al.
JOURNAL OF HEPATOLOGY (2008)
Benefits of lifestyle modification in NAFLD
Stephen A. Harrison et al.
GUT (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice
Marion A. M. den Boer et al.
ENDOCRINOLOGY (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance
Herbert Tilg et al.
GASTROENTEROLOGY (2006)
Oleoylethanolamide, an endogenous PPAR-α agonist, lowers body weight and hyperlipidemia in obese rats
J Fu et al.
NEUROPHARMACOLOGY (2005)
Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice
E Ip et al.
HEPATOLOGY (2004)
PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats
T Toyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α
J Fu et al.
NATURE (2003)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
